Cellectis S.A. ADR (CLLS)

$19.43 0.77 (4.13%)
16:00 EDT CLLS Stock Quote Delayed 30 Minutes

Investing in CRISPR Stocks: Ultimate Genetic Editing Guide

The biotech space is on the verge of hypergrowth, thanks to a scientific breakthrough in genetic editing. This is your ultimate guide to understanding and profiting from CRISPR stocks.

7 CRISPR Stocks for the Future of Medicine

5 Great Biotech Stocks to Buy Now (CLLS, CELG, EXAS, EXEL, SNSS)

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 126,600
Day's Range 18.85 - 19.60
52-Week Range 9.60 - 34.71
Dividend & Yield N/A (N/A)